Collegium Pharmaceutical (COLL) Operating Income (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Operating Income of $30.9 million for Q1 2026, up 42.46% year-over-year from $21.7 million in Q1 2025, and down 49.15% quarter-over-quarter from $60.8 million in Q4 2025.
Collegium Pharmaceutical (COLL) Operating Income (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Operating Income history runs 13 years deep, the most recent figure standing at $30.9 million for Q1 2026.
- In Q1 2026, Operating Income rose 42.46% year-over-year to $30.9 million; the TTM figure through Mar 2026 stood at $188.8 million (up 32.89% YoY), while the FY2025 annual figure was $179.6 million, up 5.73% from the prior year.
- Operating Income for Q1 2026 stood at $30.9 million, down from $60.8 million in the prior quarter.
- The five-year high for Operating Income was $62.1 million in Q3 2025, with the low at -$10.0 million in Q1 2022.
- The 5-year median for Operating Income is $35.1 million (2025), against an average of $34.2 million.
- The sharpest annual moves came in 2022 and 2023: Operating Income tumbled 147.26% in 2022, then jumped 424.69% in 2023.
- Collegium Pharmaceutical's Operating Income stood at $11.8 million in 2022, then surged by 424.69% to $61.7 million in 2023, then tumbled by 38.22% to $38.1 million in 2024, then jumped by 59.42% to $60.8 million in 2025, then slumped by 49.15% to $30.9 million in 2026.
- Business Quant data shows COLL's Operating Income at $30.9 million in Q1 2026, $60.8 million in Q4 2025, and $62.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Collegium Pharmaceutical | 899.49 Mn | 750.17 Mn | 110.29 Mn | 3.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.70 Mn |
| Mar 31, 2026 | 30.90 Mn |
| Dec 31, 2025 | 60.76 Mn |
| Sep 30, 2025 | 62.09 Mn |
| Jun 30, 2025 | 35.11 Mn |
| Mar 31, 2025 | 21.69 Mn |
| Dec 31, 2024 | 38.11 Mn |
| Sep 30, 2024 | 34.84 Mn |
| Jun 30, 2024 | 47.47 Mn |
| Mar 31, 2024 | 49.47 Mn |
| Dec 31, 2023 | 61.69 Mn |
| Sep 30, 2023 | 45.01 Mn |
| Jun 30, 2023 | 35.63 Mn |
| Mar 31, 2023 | 24.63 Mn |
| Dec 31, 2022 | 11.76 Mn |
| Sep 30, 2022 | 20.47 Mn |
| Jun 30, 2022 | 11.11 Mn |
| Mar 31, 2022 | -10.02 Mn |
| Dec 31, 2021 | -34.12 Mn |
| Sep 30, 2021 | 14.15 Mn |